☆ 4.2 Review

Overcoming Barriers to Autologous Stem Cell Transplantation in Multiple Myeloma: Recommendations from a Multidisciplinary Roundtable Discussion

TRANSPLANTATION AND CELLULAR THERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

An Iterative Formative Evaluation of Medical Education for Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant

Sean N. Halpin et al.

Summary: This article investigates ways to improve education for patients with multiple myeloma undergoing transplant. Through a formative evaluation of patient education, barriers and facilitators to patient understanding of transplant education were identified. To address social and psychological factors, the authors developed a supplemental video-based education program that provides generalized information and can be tailored to individual patient needs during in-person meetings.

JOURNAL OF CANCER EDUCATION (2022)

Add to Collection

Review Medicine, General & Internal

Diagnosis and Management of Multiple Myeloma A Review

Andrew J. Cowan et al.

Summary: Multiple myeloma is a hematologic malignancy characterized by abnormal plasma cells in the bone marrow, often leading to anemia, bone disease, and kidney injury. Diagnosis involves measuring various biomarkers, while treatment options include chemotherapy, autologous hematopoietic stem cell transplantation, and maintenance therapy.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Review Health Care Sciences & Services

Online Health Information Seeking Behaviors Among Older Adults: Systematic Scoping Review

Yuxiang Chris Zhao et al.

Summary: This systematic scoping review aims to understand older adults' online health information seeking behavior, indicating that older adults seek 10 types of health information from internet sources and encounter individual, social, and technological barriers in their OHIS. The study also suggests the need for more research to better support older adults in making informed health decisions online, proposing various objectives for future studies.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Add to Collection

Review Health Care Sciences & Services

The Effect of Online Health Information Seeking on Physician-Patient Relationships: Systematic Review

Aijing Luo et al.

Summary: The study systematically investigates the impact of OHI-seeking behavior on the physician-patient relationship. The findings show that OHI-seeking behavior affects patients' psychology, behavior, and evaluation of doctors. The discussion of OHI with doctors has different effects on the physician-patient relationship. The negative impact of OHI on Chinese internet users is noteworthy, and improving health information literacy and the quality of OHI are important factors for promoting a positive impact on the physician-patient relationship.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Add to Collection

Article Hematology

Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

S. Vincent Rajkumar

Summary: Multiple myeloma is a hematologic malignancy that accounts for approximately 10% of cases. The diagnosis is based on the presence of clonal bone marrow plasma cells and associated symptoms. High-risk patients require stem cell transplantation and may benefit from different treatment regimens.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Add to Collection

Article Oncology

Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era

Brad Rybinski et al.

Summary: Prolonged lenalidomide treatment does not significantly affect stem cell collection in the context of modern mobilization regimens.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)

Add to Collection

Article Medicine, General & Internal

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

Paul G. Richardson et al.

Summary: In patients with newly diagnosed multiple myeloma, adding autologous stem-cell transplantation to triplet therapy (RVD) can prolong progression-free survival.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Anna Waszczuk-Gajda et al.

Summary: This post hoc analysis evaluated the rate of infectious and non-infectious complications after ASCT in multiple myeloma patients. The analysis included 3552 patients and found that complication rates decreased over time. Bacterial infections and gastrointestinal complications were the most common early events. The occurrence of complications was not associated with overall survival.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Oncology

Quality of Online Information on Multiple Myeloma Available for Laypersons

Henrike Staemmler et al.

Summary: Online information has the potential to enhance patients' abilities and involvement, but concerns exist regarding the validity of the information. An evaluation of websites and videos related to multiple myeloma revealed that the overall quality was poor, with low patient-focused quality and content level. Incorporating quality indices and regular review is necessary.

CURRENT ONCOLOGY (2022)

Add to Collection

Article Oncology

Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data

Gurbakhash Kaur et al.

Summary: Hispanics with multiple myeloma present at a younger age, with lower-stage disease, and higher incidence of renal dysfunction. When provided with equal access to care, Hispanics have similar overall survival as non-Hispanic whites and non-Hispanic blacks.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

Add to Collection

Review Oncology

The role of autologous stem-cell transplantation in multiple myeloma in 2021

Roberto Mina et al.

Summary: HDM-ASCT remains the standard of care for upfront treatment of newly diagnosed MM patients. Despite some unresolved issues, attempts to replace HDM-ASCT with novel-agent-based strategies have not been successful in terms of efficacy.

CURRENT OPINION IN ONCOLOGY (2021)

Add to Collection

Review Oncology

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

Evangelos Terpos et al.

LEUKEMIA (2020)

Add to Collection

Article Oncology

Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma

Aaron S. Rosenberg et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Add to Collection

Article Oncology

Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma

Aaron S. Rosenberg et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Add to Collection

Letter Hematology

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study

Nathanael R. Fillmore et al.

BLOOD (2019)

Add to Collection

Review Public, Environmental & Occupational Health

Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies

Thomas W. LeBlanc et al.

PATIENT EDUCATION AND COUNSELING (2019)

Add to Collection

Article Oncology

Determinants of satisfactory patient communication and shared decision making in patients with multiple myeloma

Babak Nejati et al.

PSYCHO-ONCOLOGY (2019)

Add to Collection

Review Oncology

Management of Newly Diagnosed Elderly Multiple Myeloma Patients

Crystal Antoine-Pepeljugoski et al.

CURRENT ONCOLOGY REPORTS (2019)

Add to Collection

Review Oncology

Current status of autologous stem cell transplantation for multiple myeloma

Rama Al Hamed et al.

BLOOD CANCER JOURNAL (2019)

Add to Collection

Review Hematology

Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing

Shaji K. Kumar et al.

BLOOD (2019)

Add to Collection

Article Hematology

Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma

Ankit Kansagra et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Add to Collection

Editorial Material Oncology

Cancer Diagnosis: A Trauma for Patients and Doctors Alike

Frank Gieseler et al.

ONCOLOGIST (2018)

Add to Collection

Meeting Abstract Economics

REAL-LIFE AUTOLOGOUS STEM CELL TRANSPLANTATION AND OVERALL SURVIVAL RATES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: AN ANALYSIS BASED ON A GERMAN CLAIMS DATASET

S. Mueller et al.

VALUE IN HEALTH (2018)

Add to Collection

Article Hematology

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

E. Dianne Pulte et al.

BLOOD ADVANCES (2018)

Add to Collection

Article Oncology

Mixed outpatient-inpatient autologous stem cell transplant for multiple myeloma: A cost-saving initiative in a resource constrained environment

Amber B. Clemmons et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2017)

Add to Collection

Review Health Care Sciences & Services

Internet Health Information Seeking and the Patient-Physician Relationship: A Systematic Review

Sharon Swee-Lin Tan et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2017)

Add to Collection

Editorial Material Medicine, General & Internal

Transplantation for Myeloma - Now or Later?

Charles A. Schiffer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Review Health Care Sciences & Services

Advances in delivery of ambulatory autologous stem cell transplantation for multiple myeloma

Jack Khouri et al.

CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2017)

Add to Collection

Article Oncology

Hispanics Have the Lowest Stem Cell Transplant Utilization Rate for Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the United States: A CIBMTR Report

Jeffrey R. Schriber et al.

CANCER (2017)

Add to Collection

Article Hematology

Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database

Gunjan L. Shah et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)

Add to Collection

Article Hematology

Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation

Nina Shah et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)

Add to Collection

Article Oncology

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Article Oncology

The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma

Aaron N. Winn et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Add to Collection

Article Oncology

The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma

Aaron N. Winn et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Add to Collection

Article Surgery

Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma

Chintan Pandya et al.

CLINICAL TRANSPLANTATION (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.